Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin gets USFDA nod for generic equivalent of Northera Capsules

Ruchika Sharma20 Feb 2021 11:25 AM IST

Mumbai, Baltimore: Global pharma major, Lupin Limited, has recently announced that the company has received approval for its Droxidopa Capsules, 100...

GSK, Vir Biotechnology expand coronavirus collaboration to include new therapies including influenza

Ruchika Sharma20 Feb 2021 9:30 AM IST

London: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced they have signed a binding agreement to expand their existing...

Demands for immediate reform of the Pharmacy profession raised

Ruchika Sharma19 Feb 2021 4:21 PM IST

New Delhi: Raising the issues that are currently plaguing the pharmacy profession, the umbrella body of pharmacists, Indian Pharmacists...

Unichem Labs plaque psoriasis drug Apremilast gets USFDA nod

Ruchika Sharma19 Feb 2021 2:00 PM IST

Mumbai: Unichem Laboratories Limited, today announced that the company has received abbreviated new drug application (ANDA) approval for its...

Pfizer shot elicits fewer antibodies vs. South Africa strain: Bloomberg Report

Ruchika Sharma19 Feb 2021 1:30 PM IST

Pfizer and BioNTech said in a statement that there's no real-world evidence that the South African variant can elude their shot.

Zydus Cadila secures USFDA nod for Droxidopa Capsules to treat low blood pressure

Ruchika Sharma19 Feb 2021 1:05 PM IST

Ahmedabad: Pharma major, Zydus Cadila, today announced that the company has received final approval from the USFDA to market Droxidopa Capsules, 100...

Dr Reddy's Labs launches generic Prolixin tablets in US

Ruchika Sharma19 Feb 2021 12:08 PM IST

Hyderabad and Princeton: Drug major, Dr. Reddy's Laboratories Ltd., has recently announced the launch of Fluphenazine Hydrochloride Tablets,...

Bharat Biotech pursues Covaxin nod in more than 40 countries

Ruchika Sharma19 Feb 2021 11:51 AM IST

COVAXIN is one of the two vaccines approved for emergency use in India, though efficacy data from its late-stage trial is yet to be published.

61 percent of Indians keen on taking Covid-19 vaccine, prefer Covishield over Covaxin: GOQii India Fit Report

Ruchika Sharma18 Feb 2021 5:39 PM IST

Mumbai: With the COVID-19 pandemic, the world witnessed an upheaval of everything familiar, whether it be daily habits, fitness routines, forms...

COVID-19: North Korean hackers attempted to steal Pfizer vaccine technology, claims intelligence agency

Ruchika Sharma18 Feb 2021 1:55 PM IST

Health experts have said the North's hackers may be more interested in selling the stolen data than using it to develop a homegrown vaccine.

UK auditing Serum Institute site amid scramble for shots: Report

Ruchika Sharma18 Feb 2021 1:18 PM IST

New Delhi: Britain's drug regulator is auditing manufacturing processes at Serum Institute of India (SII) which could pave the way for AstraZeneca's...

Sanofi, Bristol Myers directed to pay USD 834 million over Plavix warning label

Ruchika Sharma18 Feb 2021 12:44 PM IST

Ochiai, who presided over a four week, non jury trial conducted entirely over Zoom due to the COVID-19 pandemic, ordered Bristol Myers and Sanofi to...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok